ELDN · Eledon Pharmaceuticals Inc
United States · RS rating 37 · As of 2026-11-03
| Price | 2.62 USD |
|---|---|
| 1-day change | +0.0% |
| RS rating (overall / 1M / 3M / 12M) | 37 / 71 / 27 / 26 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 26 / 33 / 30 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +18.2% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +39.9% |
| Market cap (USD) | $285.9M |